None of the nine genes had methylation detected in the 13 control samples. However, methylation for these genes was common in ocular adnexal MALT lymphomas. The detailed results for the methylation of nine genes and the presence of
C. psittaci DNA in each lineage of MALT lymphoma are given in
Table 2. Each of the nine genes showed methylation of CpG islands in the promoter region at frequencies of 0 to 94.3% (
Fig. 1). In particular, two genes (
DAPK and
ECAD) were frequently methylated (>70%). Interestingly, there was no case showing
RASSF1A and
p14 hypermethylation. All of the ocular adnexal MALT lymphoma cases had promoter hypermethylation in at least one of these genes.
C. psittaci DNA was observed in 25 (75.8%) of 33 patients with available tumor tissues (
Fig. 2). The methylation frequencies of each gene were not correlated with age group, clinical stage, or response to treatment, and the detailed
P values are demonstrated in
Table 3. The associations between sex and
RAR-β and between laterality and
DAPK were statistically significant in univariate analysis, but there was no significance in the Cox regression hazard model. In terms of
C. psittaci infection, only
ECAD showed statistical significance (
P = 0.04, Fisher's exact test). In 28 patients who were followed up for more than 6 months, 18 patients were treated with doxycycline monotherapy, 8 patients with chemotherapy, and 1 patient with primary radiation therapy. One patient underwent no initial treatment based on patient preference. In 18 patients who received doxycycline monotherapy, the response rate to the treatment was 66.7% (12/18) with a median follow-up of 16 months (
Fig. 3). Five patients received a 3-week doxycycline treatment and the other 13 patients a 6-week treatment, and the response rate was not statistically different between the two regimens (40.0% and 76.9%, respectively,
P = 0.26). However, the response to doxycycline was not significantly correlated with the methylation frequencies of each gene (
Table 3). In the chemotherapy group, the response rate was 62.5% (5/8) with a 59-month follow-up and was not significantly correlated with methylation frequencies of each gene (
Table 3).